Table 1. Combination of carfilzomib with vorinostat induced G2-M arrest.
Cell cycle | Control | CFZ | VOR | CFZ and VOR |
---|---|---|---|---|
MOLT-4 | ||||
G0G1 | 44.9 + 3.1 | 22.8 + 1.7 | 44.8 + 2.7 | 35.8 + 3.1 |
G2-M | 12.3 + 1.5 | 20.2 + 2.1** | 6.8 + 1.7 | 35.3 + 3.6† |
S | 42.7 + 2.6 | 57.1 + 3.1 | 48.3 + 2.3 | 29.0 + 4.9 |
HuT 78 | ||||
G0G1 | 54.3 + 2.7 | 44.2 + 1.7 | 54.0 + 2.7 | 41.2 + 1.6 |
G2-M | 10.1 + 1.4 | 16.7 + 1.3** | 6.3 + 1.2 | 38.0 + 2.6† |
S | 35.6 + 3.7 | 39.2 + 0.7 | 39.7 + 3.6 | 20.8 + 1.0 |
represent significant differences relative to controls (p < 0.01);
represent significant differences relative to CFZ (p < 0.001).
CFZ, carfilzomib; VOR, vorinostat.